SE8600632D0 - Novel pharmaceutical composition - Google Patents

Novel pharmaceutical composition

Info

Publication number
SE8600632D0
SE8600632D0 SE8600632A SE8600632A SE8600632D0 SE 8600632 D0 SE8600632 D0 SE 8600632D0 SE 8600632 A SE8600632 A SE 8600632A SE 8600632 A SE8600632 A SE 8600632A SE 8600632 D0 SE8600632 D0 SE 8600632D0
Authority
SE
Sweden
Prior art keywords
pharmaceutical composition
novel pharmaceutical
pregnanolone
composition
claving
Prior art date
Application number
SE8600632A
Other languages
English (en)
Swedish (sv)
Inventor
R I Jeppsson
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE8600632A priority Critical patent/SE8600632D0/xx
Publication of SE8600632D0 publication Critical patent/SE8600632D0/xx
Priority to EP87850029A priority patent/EP0233849B1/en
Priority to ES198787850029T priority patent/ES2037742T3/es
Priority to DE8787850029T priority patent/DE3770830D1/de
Priority to AT87850029T priority patent/ATE64526T1/de
Priority to DK198700621A priority patent/DK175504B1/da
Priority to NO870560A priority patent/NO175040B/no
Priority to FI870589A priority patent/FI88676C/fi
Priority to JP62028395A priority patent/JPH0788305B2/ja
Priority to CA000529609A priority patent/CA1301651C/en
Priority to US07/316,576 priority patent/US5028600A/en
Priority to GR91400996T priority patent/GR3002299T3/el
Priority to SG1028/92A priority patent/SG102892G/en
Priority to HK832/93A priority patent/HK83293A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE8600632A 1986-02-13 1986-02-13 Novel pharmaceutical composition SE8600632D0 (sv)

Priority Applications (14)

Application Number Priority Date Filing Date Title
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition
EP87850029A EP0233849B1 (en) 1986-02-13 1987-01-29 Composition of pregnanolole comprising a stable oil-in-water emulsion
ES198787850029T ES2037742T3 (es) 1986-02-13 1987-01-29 Procedimiento de obtencion de una composicion para administracion intravenosa.
DE8787850029T DE3770830D1 (de) 1986-02-13 1987-01-29 Zubereitung von pregnanolol in einer stabilen oel-in-wasser-emulsion.
AT87850029T ATE64526T1 (de) 1986-02-13 1987-01-29 Zubereitung von pregnanolol in einer stabilen oel- in-wasser-emulsion.
DK198700621A DK175504B1 (da) 1986-02-13 1987-02-06 Farmaceutisk præparat indeholdende 3alfa-hydroxy-5beta-pregnan-20-on og fremstilling deraf
CA000529609A CA1301651C (en) 1986-02-13 1987-02-12 Pharmaceutical composition containing pregnanolone
NO870560A NO175040B (no) 1986-02-13 1987-02-12 Fremgangsmåte for fremstilling av et preparat for intravenös administrering av 3
FI870589A FI88676C (fi) 1986-02-13 1987-02-12 Foerfarande foer framstaellning av en komposition foer intravenoes administrering av pregnanolon
JP62028395A JPH0788305B2 (ja) 1986-02-13 1987-02-12 静脈内投与用組成物およびその製法
US07/316,576 US5028600A (en) 1986-02-13 1989-02-28 Novel pharmaceutical composition
GR91400996T GR3002299T3 (en) 1986-02-13 1991-07-11 Composition of pregnanolole comprising a stable oil-in-water emulsion
SG1028/92A SG102892G (en) 1986-02-13 1992-10-07 Composition of pregnanolole comprising a stable oil-in-water emulsion
HK832/93A HK83293A (en) 1986-02-13 1993-08-12 Composition of pregnanolole comprising a stable oil-in-water emulsion

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition

Publications (1)

Publication Number Publication Date
SE8600632D0 true SE8600632D0 (sv) 1986-02-13

Family

ID=20363448

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8600632A SE8600632D0 (sv) 1986-02-13 1986-02-13 Novel pharmaceutical composition

Country Status (14)

Country Link
US (1) US5028600A (xx)
EP (1) EP0233849B1 (xx)
JP (1) JPH0788305B2 (xx)
AT (1) ATE64526T1 (xx)
CA (1) CA1301651C (xx)
DE (1) DE3770830D1 (xx)
DK (1) DK175504B1 (xx)
ES (1) ES2037742T3 (xx)
FI (1) FI88676C (xx)
GR (1) GR3002299T3 (xx)
HK (1) HK83293A (xx)
NO (1) NO175040B (xx)
SE (1) SE8600632D0 (xx)
SG (1) SG102892G (xx)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9302295D0 (sv) * 1993-07-02 1993-07-02 Kabi Pharmacia Ab New pharmaceutical composition
US5616330A (en) * 1994-07-19 1997-04-01 Hemagen/Pfc Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
US20020155161A1 (en) * 2000-12-29 2002-10-24 Deckelbaum Richard J. Use of IV emulsions with different triglyceride composition, particle size and apolipoprotein E for targeted tissue delivery of hydrophobic compounds
EP3513813A1 (en) * 2002-07-02 2019-07-24 Astrazeneca Ciclesonide-containing sterile aqueous suspension
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
EA200700440A1 (ru) * 2004-09-13 2008-02-28 Бхарат Сирумс Энд Вэксинс Лтд. Композиции стабильных эмульсий для внутривенного введения, имеющие защитную эффективность
WO2012096697A1 (en) * 2011-01-14 2012-07-19 Simpkins Cuthbert O Methods and compositions for treating conditions related to lack of blood supply, shock and neuronal injuries
WO2013043985A1 (en) * 2011-09-23 2013-03-28 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
SG10201606063RA (en) 2012-01-23 2016-09-29 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
WO2014028398A2 (en) 2012-08-13 2014-02-20 The Regents Of The University Of California Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
IL304912A (en) 2012-08-21 2023-10-01 Sage Therapeutics Inc Treatment methods for epilepsy and status epilepticus
EP2925327B1 (en) 2012-11-30 2024-01-10 The Regents of The University of California Allopregnanolone for treating, reducing or mitigating symptoms of post-partum depression
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
WO2017156103A1 (en) 2016-03-08 2017-09-14 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
JP2022514991A (ja) * 2018-12-10 2022-02-16 ハロー・サイエンス・エル・エル・シー 安定な麻酔薬製剤および関連する剤形
CA3151334C (en) * 2019-08-19 2024-04-09 Arizona Board Of Regents On Behalf Of The University Of Arizona Topical neurosteroid formulations
CN114344309B (zh) * 2021-12-30 2024-02-06 南京迈诺威医药科技有限公司 一种别孕烷醇酮衍生物自乳化制剂及其制备方法
US11969434B1 (en) 2022-08-29 2024-04-30 Lipocine Inc. Oral allopregnanolone compositions and methods of use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1215702B (de) * 1962-07-03 1966-05-05 Merck Ag E Verfahren zur Herstellung von 1alpha-Alkylthio-3-keto-androstanen
CA895860A (en) * 1969-11-05 1972-03-21 Kruger Gunther PROCESS FOR THE PREPARATION OF 3.alpha.-HYDROXY-5.beta.-PREGNAN-20-ONE
US3917830A (en) * 1970-12-17 1975-11-04 Glaxo Lab Ltd Steroidal anaesthetic composition for intraveneous injection
US3900561A (en) * 1970-12-17 1975-08-19 Glaxo Lab Ltd Pharmaceutical compositions
US4168308A (en) * 1976-03-12 1979-09-18 Apoteksvarucentralen Vitrum Ab Composition for enhancing the administration of pharmacologically active agents
JPS609726B2 (ja) * 1980-05-15 1985-03-12 株式会社 ミドリ十字 ステロイド製剤
JPS5716818A (en) * 1981-04-25 1982-01-28 Green Cross Corp:The Steroid fatty emulsion
JPS60258110A (ja) * 1984-06-05 1985-12-20 Daigo Eiyou Kagaku Kk 静脈注射可能なプロゲステロン乳化注射液

Also Published As

Publication number Publication date
NO175040C (xx) 1994-08-24
GR3002299T3 (en) 1992-12-30
ATE64526T1 (de) 1991-07-15
US5028600A (en) 1991-07-02
FI88676B (fi) 1993-03-15
FI88676C (fi) 1993-06-28
DK62187A (da) 1987-08-14
DE3770830D1 (de) 1991-07-25
JPH0788305B2 (ja) 1995-09-27
CA1301651C (en) 1992-05-26
HK83293A (en) 1993-08-20
FI870589A0 (fi) 1987-02-12
NO175040B (no) 1994-05-16
EP0233849B1 (en) 1991-06-19
EP0233849A1 (en) 1987-08-26
ES2037742T3 (es) 1993-07-01
DK175504B1 (da) 2004-11-15
NO870560D0 (no) 1987-02-12
FI870589A (fi) 1987-08-14
NO870560L (no) 1987-08-14
DK62187D0 (da) 1987-02-06
SG102892G (en) 1992-12-04
JPS62192322A (ja) 1987-08-22

Similar Documents

Publication Publication Date Title
SE8600632D0 (sv) Novel pharmaceutical composition
NO175620C (no) Fremgangsmåte for fremstilling av et antitumorvirksomt legemiddel
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
EE03223B1 (et) Kiiretoimelist dihüdropüridiinühendit sisaldav farmatseutiline emulsioon vererõhu alandamiseks ja selle valmistamise protsess
FR2362833A1 (fr) Nouveaux derives 5 de prostaglandine, leur procede de preparation et medicament les contenant
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ES2062610T3 (es) Compuesto diarilico anti-ateroesclerotico.
NO881616L (no) Middel til innsekts- og middbekjempelse.
GR1001597B (el) Νέα βιολογικώς δραστικά παράγωγα εμπουρναμενίνης, φαρμακευτικές συν?έσεις οι οποίες περιέχουν αυτά και μέ?οδος δια την παρασκευή αυτών.
DZ1468A1 (fr) Composés nouveaux.
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant
FR2375211A1 (fr) Nouveaux acides sulfamoylbenzoiques, leur preparation et leur application en tant que medicaments
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
KR880012226A (ko) 외 용 제
FR2422647A1 (fr) Nouvelles 2,4-diamino-5-benzylpyrimidines, leur preparation et leur application en tant que medicaments
ES8704489A1 (es) Procedimiento para preparar derivados de 3, 4-diazol
ATE98478T1 (de) Calcitonin enthaltende pharmazeutische zusammensetzungen.
ES8502869A1 (es) Procedimiento para la estabilizacion de preparados farmaceuticos de prostaglandinas.
ATE145647T1 (de) Gem-diphosphonsäure-nitrosocarbamoylderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zubereitungen
SE8704049D0 (sv) Novel pharmacological compounds
KR890001582A (ko) 향류머티스제
KR920000327A (ko) 비스(3,5-디-알킬-4- 히드록시페닐티오) 메탄을 유효 성분으로 함유하는 고트리글리세리드혈증 치료용 제약 조성물
ES2019156A6 (es) Procedimiento para preparar esteres adamantilicos liposolubles de vitamina c.